Literature DB >> 9671775

Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.

R T Matthews1, L Yang, S Browne, M Baik, M F Beal.   

Abstract

Coenzyme Q10 is an essential cofactor of the electron transport chain as well as a potent free radical scavenger in lipid and mitochondrial membranes. Feeding with coenzyme Q10 increased cerebral cortex concentrations in 12- and 24-month-old rats. In 12-month-old rats administration of coenzyme Q10 resulted in significant increases in cerebral cortex mitochondrial concentrations of coenzyme Q10. Oral administration of coenzyme Q10 markedly attenuated striatal lesions produced by systemic administration of 3-nitropropionic acid and significantly increased life span in a transgenic mouse model of familial amyotrophic lateral sclerosis. These results show that oral administration of coenzyme Q10 increases both brain and brain mitochondrial concentrations. They provide further evidence that coenzyme Q10 can exert neuroprotective effects that might be useful in the treatment of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671775      PMCID: PMC21173          DOI: 10.1073/pnas.95.15.8892

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Cortical cytochrome oxidase activity is reduced in Alzheimer's disease.

Authors:  E M Mutisya; A C Bowling; M F Beal
Journal:  J Neurochem       Date:  1994-12       Impact factor: 5.372

2.  Preservation of mitochondrial respiratory function by coenzyme Q10 in aged rat skeletal muscle.

Authors:  S Sugiyama; K Yamada; T Ozawa
Journal:  Biochem Mol Biol Int       Date:  1995-12

3.  Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice.

Authors:  M F Beal; R T Matthews; A Tieleman; C W Shults
Journal:  Brain Res       Date:  1998-02-02       Impact factor: 3.252

4.  Enhanced sensitivity of ubiquinone-deficient mutants of Saccharomyces cerevisiae to products of autoxidized polyunsaturated fatty acids.

Authors:  T Q Do; J R Schultz; C F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  Ubiquinone-10 protects neurons from virus-induced degeneration.

Authors:  C Edlund; K Holmberg; G Dallner; E Norrby; K Kristensson
Journal:  J Neurochem       Date:  1994-08       Impact factor: 5.372

6.  Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.

Authors:  A Sanbe; K Tanonaka; Y Niwano; S Takeo
Journal:  J Pharmacol Exp Ther       Date:  1994-04       Impact factor: 4.030

7.  Relations between tocopherol depletion and coenzyme Q during lipid peroxidation in rat liver mitochondria.

Authors:  H Noack; U Kube; W Augustin
Journal:  Free Radic Res       Date:  1994-06

8.  Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate.

Authors:  M F Beal; D R Henshaw; B G Jenkins; B R Rosen; J B Schulz
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

9.  Ubisemiquinones as obligatory intermediates in the electron transfer from NADH to ubiquinone.

Authors:  A M De Jong; S P Albracht
Journal:  Eur J Biochem       Date:  1994-06-15

10.  Protective effect of exogenous coenzyme Q against damage by adriamycin in perfused rat liver.

Authors:  V Valls; C Castelluccio; R Fato; M L Genova; C Bovina; G Saez; M Marchetti; G Parenti Castelli; G Lenaz
Journal:  Biochem Mol Biol Int       Date:  1994-07
View more
  131 in total

Review 1.  Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.

Authors:  M Flint Beal
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

Review 2.  Complex genetics of amyotrophic lateral sclerosis.

Authors:  Catherine B Kunst
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

Review 3.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

4.  Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.

Authors:  Miriam A Hickey; Chunni Zhu; Vera Medvedeva; Nicholas R Franich; Michael S Levine; Marie-Françoise Chesselet
Journal:  Mol Cell Neurosci       Date:  2011-10-20       Impact factor: 4.314

5.  Oral repeated-dose toxicity studies of coenzyme Q10 in beagle dogs.

Authors:  Padmaja Yerramilli-Rao; M Flint Beal; Dai Watanabe; Karl Kieburtz; Elisabeth A de Blieck; Mitsuaki Kitano; Kazunori Hosoe; Iwao Funahashi; Merit E Cudkowicz
Journal:  Int J Toxicol       Date:  2012-01-20       Impact factor: 2.032

Review 6.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

7.  Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity.

Authors:  Muralikrishnan Dhanasekaran; Christian B Albano; Lori Pellet; Senthilkumar S Karuppagounder; Subramaniam Uthayathas; Vishnu Suppiramaniam; Holly Brown-Borg; Manuchair Ebadi
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

Review 8.  Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas.

Authors:  Russel J Reiter; Sergio Rosales-Corral; Dun Xian Tan; Mei Jie Jou; Annia Galano; Bing Xu
Journal:  Cell Mol Life Sci       Date:  2017-09-01       Impact factor: 9.261

Review 9.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

10.  Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.

Authors:  Marianna Sikorska; Patricia Lanthier; Harvey Miller; Melissa Beyers; Caroline Sodja; Bogdan Zurakowski; Sandhya Gangaraju; Siyaram Pandey; Jagdeep K Sandhu
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.